# EDGAR Filing Document

**Accession Number:** 0001402328
**File Stem:** 0001683168-25-005976
**Filing Date:** 2025-8
**Character Count:** 2665
**Document Hash:** 58ca5acc42e3b096bbc2c508ef029087
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001683168-25-005976.hdr.sgml**: 20250812

**ACCESSION NUMBER**: 0001683168-25-005976

**CONFORMED SUBMISSION TYPE**: RW

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250812

**DATE AS OF CHANGE**: 20250812

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Sunshine Biopharma Inc.
- **CENTRAL INDEX KEY:** 0001402328
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 205566275
- **STATE OF INCORPORATION:** CO
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** RW

**SEC ACT:**
- **SEC FILE NUMBER:** 333-276817
- **FILM NUMBER:** 251207445

**BUSINESS ADDRESS:**
- **STREET 1:** 333 LAS OLAS WAY
- **STREET 2:** CU4 SUITE 433
- **CITY:** FORT LAUDERDALE
- **STATE:** FL
- **ZIP:** 33301
- **BUSINESS PHONE:** 954-330-0684

**MAIL ADDRESS:**
- **STREET 1:** 333 LAS OLAS WAY
- **STREET 2:** CU4 SUITE 433
- **CITY:** FORT LAUDERDALE
- **STATE:** FL
- **ZIP:** 33301

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Sunshine Biopharma, Inc
- **DATE OF NAME CHANGE:** 20091102

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Mountain West Business Solutions, Inc
- **DATE OF NAME CHANGE:** 20071030

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** mountain west business solutions,inc
- **DATE OF NAME CHANGE:** 20070607

**Sunshine Biopharma Inc.**

**333 Las Olas Way, CU4 Suite 433**

**Fort Lauderdale, FL 33301**

August 12, 2025

<u>VIA EDGAR</u>

Securities and Exchange Commission

Division of Corporation Finance

100 F. Street, N.E.

Washington, D.C. 20549

---

| | |
|:---|:---|
| **Re:** | **Sunshine Biopharma Inc.** |
|  | **Post-Effective Amendment No. 2 to Registration Statement on Form S-1** |
|  | **Filed July 25, 2025** |
|  | **File No. 333-276817** |

---

Dear Sir or Madam:

Pursuant to Rule 477 promulgated under the Securities Act of 1933, as amended, Sunshine Biopharma Inc. (the "Company") hereby requests that the Securities and Exchange Commission consent to the withdrawal of the Company's Post-Effective Amendment No. 2 to Registration Statement on Form S-1 (Registration No. 333-276817) (the "Post-Effective Amendment"). The Company is requesting withdrawal of the Post-Effective Amendment because the Company has filed a new registration statement for the securities it sought to have registered under the Post-Effective Amendment. No securities were sold pursuant to the Post-Effective Amendment.

Thank you for your assistance in this matter.

Very truly yours,

Sunshine Biopharma Inc.

By*: <u>/s/ Dr. Steve N. Slilaty</u>*

Name: Dr. Steve N. Slilaty

Title: Chief Executive Officer